Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Armon

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
The British Journal of Ophthalmology|February 11, 2025
Incidence, sociodemographic and presenting clinical features of childhood non-infectious uveitis: findings from the UK national inception cohort studyAmeenat Lola Solebo, Salomey Kellett, Eibhlin McLoone, et al.
Rheumatology (Oxford, England)|August 21, 2024
Incidence of chronic recurrent multifocal osteomyelitis in children and adolescents in the UK and Republic of IrelandDaphne Theresa Chia, Andoni Paul Toms, Anish Sanghrajka, et al.
Rheumatology (Oxford, England)|January 9, 2021
Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)Samantha Cooray, Ebun Omyinmi, Ying Hong, et al.
Lancet (London, England)|January 25, 2025
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trialNisha R Acharya, Athimalaipet V Ramanan, Alison B Coyne, et al.
Arthritis and Rheumatism|February 2, 2012
Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus CohortLouise Watson, Valentina Leone, Clarissa Pilkington, et al.
Reumatologia Clinica|November 14, 2025
Exploring the prevalence of pulmonary involvement in juvenile-onset systemic lupus erythematosus: Data from the UK JSLE Cohort StudyAyodele Faleye, Kamran Mahmood, Eslam Al-Abadi, et al.
Rheumatology (Oxford, England)|October 26, 2024
Contributors to organ damage in childhood lupus: corticosteroid use and disease activityMaria Hanif, Chandni Sarker, Eslam Al-Abadi, et al.
Rheumatology (Oxford, England)|April 3, 2014
Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patientsDirekrit Chiewchengchol, Ruth Murphy, Thomas Morgan, et al.
Lupus|January 8, 2021
Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UKJoseph S Massias, Eve Md Smith, Eslam Al-Abadi, et al.
Rheumatology (Oxford, England)|December 11, 2021
Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupusEve M D Smith, Kukatharmini Tharmaratnam, Eslam Al-Abadi, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
The British Journal of Ophthalmology|February 11, 2025
Incidence, sociodemographic and presenting clinical features of childhood non-infectious uveitis: findings from the UK national inception cohort studyAmeenat Lola Solebo, Salomey Kellett, Eibhlin McLoone, et al.
Rheumatology (Oxford, England)|August 21, 2024
Incidence of chronic recurrent multifocal osteomyelitis in children and adolescents in the UK and Republic of IrelandDaphne Theresa Chia, Andoni Paul Toms, Anish Sanghrajka, et al.
Rheumatology (Oxford, England)|January 9, 2021
Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)Samantha Cooray, Ebun Omyinmi, Ying Hong, et al.
Lancet (London, England)|January 25, 2025
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trialNisha R Acharya, Athimalaipet V Ramanan, Alison B Coyne, et al.
Arthritis and Rheumatism|February 2, 2012
Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus CohortLouise Watson, Valentina Leone, Clarissa Pilkington, et al.
Reumatologia Clinica|November 14, 2025
Exploring the prevalence of pulmonary involvement in juvenile-onset systemic lupus erythematosus: Data from the UK JSLE Cohort StudyAyodele Faleye, Kamran Mahmood, Eslam Al-Abadi, et al.
Rheumatology (Oxford, England)|October 26, 2024
Contributors to organ damage in childhood lupus: corticosteroid use and disease activityMaria Hanif, Chandni Sarker, Eslam Al-Abadi, et al.
Rheumatology (Oxford, England)|April 3, 2014
Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patientsDirekrit Chiewchengchol, Ruth Murphy, Thomas Morgan, et al.
Lupus|January 8, 2021
Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UKJoseph S Massias, Eve Md Smith, Eslam Al-Abadi, et al.
Rheumatology (Oxford, England)|December 11, 2021
Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupusEve M D Smith, Kukatharmini Tharmaratnam, Eslam Al-Abadi, et al.
Pageof 3